Tirzepatide and Semaglutide are two groundbreaking medications for managing Type 2 diabetes andaiding weight loss. They are both part of the GLP-1 receptor agonists class, but Tirzepatide has anadditional action as a GIP receptor agonist. Understanding their mechanisms, benefits, and sideeffects can help you make an informed decision about your treatment options. Mechanisms of Action […]

Read More